(Q41267462)

28 September 2017

title

Multifactorial genesis of enhanced platelet aggregability in patients with nephrotic syndrome (English)

1 reference

28 September 2017

Machleidt C

1

1 reference

28 September 2017

Mettang T

2

1 reference

28 September 2017

Stärz E

3

1 reference

28 September 2017

Weber J

4

1 reference

28 September 2017

Risler T

5

1 reference

28 September 2017

Kuhlmann U

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

28 September 2017

1 reference

28 September 2017

volume

36

1 reference

28 September 2017

issue

6

1 reference

28 September 2017

page(s)

1119-1124

1 reference

Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Comprehensive study of haemostasis in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Clinical correlation between hypercoagulability and thrombo-embolic phenomena

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Platelet hyperaggregability and the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Platelet hyperaggregability as a consequence of the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Nephrotic syndrome: increased platelet prostaglandin endoperoxide formation, hyperaggregability, and reduced platelet life span. Reversal following remission

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

On the inhibitory effect of albumin on platelet aggregation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

β-thromboglobulin levels in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

The metabolism of arachidonic acid by platelets in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Storage of platelets for tests of platelet function: comparison of two methods of pH control

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

EFFECTS OF INORGANIC IONS AND OF PLASMA PROTEINS ON THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Beta-thromboglobulin is elevated in renal failure without thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Different effects of renal failure on beta-thromboglobulin and high affinity platelet factor 4 (HA-PF4)-concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Epidemiological characteristics of platelet aggregability.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

The use of high pressure liquid chromatography (HPLC) for the separation of radiolabeled arachidonic acid and its metabolites produced by thrombin-treated human platelets. II. Establishment of optimal assay conditions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Platelet hypersensitivity induced by cholesterol incorporation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Effect of cholesterol on production of thromboxane b2 by platelets in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Platelet aggregation: cellular regulation and physiologic role

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

The effect of physiological levels of fibrinogen on platelet aggregation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1989.310

7 January 2021

Identifiers

DOI

10.1038/KI.1989.310

1 reference

Dimensions Publication ID

28 September 2017

1041968123

0 references

1 reference